Below you will find example sentences with "edwards lifesciences". The examples show how this phrase is used in natural context and which words often surround it.
Edwards Lifesciences in a sentence
Corpus data
- Displayed example sentences: 20
- Discovered as a combination around: edwards
- Corpus frequency in the collocation scan: 10
- Phrase length: 2 words
- Average sentence length: 20.9 words
Sentence profile
- Phrase position: 6 start, 14 middle, 0 end
- Sentence types: 20 statements, 0 questions, 0 exclamations
Corpus analysis
- The phrase "edwards lifesciences" has 2 words and usually appears in the middle in these examples. The average sentence has 20.9 words and is mostly made up of statements.
- Around this phrase, patterns and context words such as edwards lifesciences last released, holdings in edwards lifesciences were worth, quarter, llc and shares stand out.
- In the phrase index, this combination connects with benjamin edwards, edwards company, edwards inc, edwards company and edwards inc, linking the page to nearby combinations.
Example types with edwards lifesciences
This selection groups the examples by length and sentence type, making usage of the full phrase easier to scan:
Edwards Lifesciences () last released its quarterly earnings data on Wednesday, July 26th. (12 words)
Edwards Lifesciences () last released its quarterly earnings results on Wednesday, July 26th. (12 words)
Edwards Lifesciences has had an impeccable record of steadily rising earnings for more than two decades. (16 words)
Edwards Lifesciences will hold an open day at its state-of-the-art facility in Limerick to allow potential new employees to gain a sense of what it is like to work for the company and if it is the job for them. (43 words)
Advisor Resource Council bought a new stake in shares of Edwards Lifesciences Co. () in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. (29 words)
Morgan Stanley reissued an “overweight” rating and issued a $102.00 price objective on shares of Edwards Lifesciences in a research report on Friday, July 14th. (26 words)
Example sentences (20)
In other Edwards Lifesciences news, VP Jean-Luc M. Lemercier sold 14,400 shares of Edwards Lifesciences stock in a transaction dated Wednesday, May 1st.
Also, CFO Scott B. Ullem sold 80,700 shares of Edwards Lifesciences stock in a transaction dated Wednesday, May 10th.
Altshuler Shaham Ltd acquired a new stake in shares of Edwards Lifesciences during the second quarter worth about $31,000.
Bogart Wealth LLC acquired a new stake in Edwards Lifesciences during the 3rd quarter valued at $25,000.
Bogart Wealth LLC purchased a new position in Edwards Lifesciences in the 3rd quarter valued at about $25,000.
Edwards Lifesciences has had an impeccable record of steadily rising earnings for more than two decades.
Edwards Lifesciences () last released its quarterly earnings data on Wednesday, July 26th.
Edwards Lifesciences () last released its quarterly earnings results on Wednesday, July 26th.
Edwards Lifesciences will hold an open day at its state-of-the-art facility in Limerick to allow potential new employees to gain a sense of what it is like to work for the company and if it is the job for them.
Moneta Group Investment Advisors LLC raised its stake in shares of Edwards Lifesciences by 104,971.3% in the 4th quarter.
Morgan Stanley reissued an “overweight” rating and issued a $102.00 price objective on shares of Edwards Lifesciences in a research report on Friday, July 14th.
On average, research analysts forecast that Edwards Lifesciences Co. will post 2.55 earnings per share for the current fiscal year.
Stonegate Investment Group LLC increased its stake in shares of Edwards Lifesciences by 22.3% in the 1st quarter.
Trifecta Capital Advisors LLC purchased a new position in Edwards Lifesciences during the fourth quarter valued at $28,000.
Truvestments Capital LLC lifted its holdings in Edwards Lifesciences by 260.0% in the second quarter.
Wagner Wealth Management LLC bought a new position in Edwards Lifesciences in the second quarter worth $44,000.
Advisor Resource Council bought a new stake in shares of Edwards Lifesciences Co. () in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Allworth Financial LP’s holdings in Edwards Lifesciences were worth $288,000 as of its most recent filing with the Securities & Exchange Commission.
AQR Capital Management LLC’s holdings in Edwards Lifesciences were worth $18,666,000 as of its most recent SEC filing.
Citigroup lowered Edwards Lifesciences from a “buy” rating to a “neutral” rating in a research note on Monday, December 11th.